As on Thursday, Solid Biosciences Inc (NASDAQ: SLDB) started slowly as it slid -5.35% to $5.31, before settling in for the price of $5.61 at the close. Taking a more long-term approach, SLDB posted a 52-week range of $2.41-$7.37.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 41.25%. Meanwhile, its Annual Earning per share during the time was 41.25%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 31.67%. This publicly-traded company’s shares outstanding now amounts to $77.88 million, simultaneously with a float of $58.88 million. The organization now has a market capitalization sitting at $413.71 million. At the time of writing, stock’s 50-day Moving Average stood at $5.23, while the 200-day Moving Average is $4.94.
Solid Biosciences Inc (SLDB) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Solid Biosciences Inc’s current insider ownership accounts for 24.42%, in contrast to 82.80% institutional ownership. According to the most recent insider trade that took place on Jan 05 ’26, this organization’s Director sold 1,053 shares at the rate of 5.43, making the entire transaction reach 5,718 in total value, affecting insider ownership by 17,278. Preceding that transaction, on Dec 03 ’25, Company’s Chief Operating Officer sold 4,932 for 5.11, making the whole transaction’s value amount to 25,203. This particular insider is now the holder of 32,908 in total.
Solid Biosciences Inc (SLDB) Earnings and Revenue Records
Solid Biosciences Inc’s EPS increase for this current 12-month fiscal period is 31.67% and is forecasted to reach -2.04 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.41% through the next 5 years, which can be compared against the 41.25% growth it accomplished over the previous five years trading on the market.
Solid Biosciences Inc (NASDAQ: SLDB) Trading Performance Indicators
Let’s observe the current performance indicators for Solid Biosciences Inc (SLDB). It’s Quick Ratio in the last reported quarter now stands at 6.74.
In the same vein, SLDB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.49, a figure that is expected to reach -0.50 in the next quarter, and analysts are predicting that it will be -2.04 at the market close of one year from today.
Technical Analysis of Solid Biosciences Inc (SLDB)
Through scrutinizing the latest numbers posted by the [Solid Biosciences Inc, SLDB], it can be observed that its last 5-days Average volume of 1.0 million was better the volume of 1.0 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 34.37% While, its Average True Range was 39.58.
Raw Stochastic average of Solid Biosciences Inc (SLDB) in the period of the previous 100 days is set at 50.67%, which indicates a major rise in contrast to 13.49% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.33 that was lower than 0.38 volatility it exhibited in the past 100-days period.
